Literature DB >> 19759508

Trend in seroprevalence of Hepatitis B virus infection among blood donors of coastal Karnataka, India.

Karandeep Singh1, Sudha Bhat, Shamee Shastry.   

Abstract

BACKGROUND: Hepatitis B is one of the transfusion transmissible infections. The prevalence of this infection varies across the different geographies. Noting the trend in seroprevalence is useful to assist the preventive strategies. The aim of this study was to determine the trend of seroprevalence of hepatitis B in costal Karnataka over a three-year period.
METHODOLOGY: The study was conducted at the blood bank of a tertiary care hospital serving predominantly the people of coastal Karnataka. A retrospective analysis of blood donors over a period of three years was done to assess the seroprevalence and the trend of hepatitis B infection. ELISA was used to detect the hepatitis B surface antigen in the donors as a marker of infection.
RESULTS: A total of 30,428 blood donors were studied. 189 (0.62%) were positive, which comes under the "low prevalence ( < 2%) zone" per World Health Organization (WHO) guidelines. A decreasing trend over three years was seen. Replacement donors and male blood donors showed higher seropositivity compared to voluntary donors and female donors. Chi-square test was used to calculate the significance of difference between the groups.
CONCLUSION: Coastal Karnataka has a low prevalence of hepatitis B in blood donors with a decreasing trend over the last three-year period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759508     DOI: 10.3855/jidc.246

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  13 in total

Review 1.  Tackling the Hepatitis B Disease Burden in India.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-12-15

2.  Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study.

Authors:  P Pallavi; C K Ganesh; K Jayashree; G V Manjunath
Journal:  Indian J Hematol Blood Transfus       Date:  2010-12-14       Impact factor: 0.900

3.  Seroprevalence and Trends of Transfusion Transmissible Infections in Blood Donors in Andaman and Nicobar Islands- An Institutional Retrospective Study.

Authors:  Sahil Sehgal; P S Shaiji; Rupinder Kaur Brar
Journal:  J Clin Diagn Res       Date:  2017-04-01

4.  Family/friend donors are not true voluntary donors.

Authors:  Rohit Jain; Gajendra Gupta
Journal:  Asian J Transfus Sci       Date:  2012-01

5.  Transfusion-transmissible infections among voluntary blood donors at Government Medical College Thiruvananthapuram, Kerala, India.

Authors:  H Anjali; Ancy Issac; M R Anjali; T S Anish
Journal:  Asian J Transfus Sci       Date:  2012-01

6.  A comprehensive serological and supplemental evaluation of hepatitis B "seroyield" blood donors: A cross-sectional study from a tertiary healthcare center in India.

Authors:  Prashant Pandey; Aseem K Tiwari; Ravi C Dara; Geet Aggarwal; Ganesh Rawat; Vimarsh Raina
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

Review 7.  Family donors are critical and legitimate in developing countries.

Authors:  Jean-Pierre Allain; Cees Th Smit Sibinga
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

8.  Laboratory evaluation of three regimens of treatment of chronic hepatitis B: tenofovir, entecavir and combination of lamivudine and adefovir.

Authors:  Rajeswari Jayakumar; Yogendra Kumar Joshi; Sarman Singh
Journal:  J Lab Physicians       Date:  2012-01

9.  HBsAg Positive Patient Characteristics in Hospital and Blood Donation Camps.

Authors:  Deepti Sachan; Joy Varghese; Jensingh Joseph; Vijaya Srinivasan; Venkataraman Jayanthi; Mohamed Rela
Journal:  ISRN Hematol       Date:  2013-09-04

10.  Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India.

Authors:  R N Makroo; Vikas Hegde; Mohit Chowdhry; Aakanksha Bhatia; N L Rosamma
Journal:  Indian J Med Res       Date:  2015-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.